{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:33:00Z","timestamp":1786735980730,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Trichol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijt.ijt_62_18","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T07:13:15Z","timestamp":1543821195000},"page":"193","source":"Crossref","is-referenced-by-count":9,"title":["A comment on JAK inhibitors for treatment of alopecia areata"],"prefix":"10.4103","volume":"10","author":[{"given":"RalphMichel","family":"Trueb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hudson","family":"Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MariaFernanda Reis Gavazzoni","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-7753.246805-1","unstructured":"Groopman J. How Doctors Think. Boston\/New York: Houghton Mifflin Company; 2007."},{"key":"key-10.4103\/0974-7753.246805-2","unstructured":"Ramot Y. The Fascinating Story of how JAK Inhibitors Became the Drug of Choice for alopecia Areata. 18th Meeting of the European Hair Research Society, Bologna, Italy; 2018."},{"key":"key-10.4103\/0974-7753.246805-3","first-page":"628","volume-title":"Incidence of alopecia areata in Olmsted county, Minnesota, 1975 through 1989","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0974-7753.246805-4","first-page":"290","volume-title":"Alopecia areata.An evaluation of 736 patients","author":"Muller","year":"1963","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0974-7753.246805-5","first-page":"348","volume-title":"Alopecia areata: Clinical presentation, diagnosis, and unusual cases","author":"Finner","year":"2011","journal-title":"Dermatol Ther"},{"key":"key-10.4103\/0974-7753.246805-6","first-page":"438","volume-title":"Alopecia areata: A long term follow-up study of 191 patients","author":"Tosti","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.246805-7","first-page":"748","volume-title":"The pattern and profile of alopecia areata in Singapore \u2013 A study of 219 Asians","author":"Tan","year":"2002","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0974-7753.246805-8","first-page":"429","volume-title":"Juvenile versus maturity-onset alopecia areata \u2013 A comparative retrospective clinical study","author":"De","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0974-7753.246805-9","first-page":"581","volume-title":"History of atopy or autoimmunity increases risk of alopecia areata","author":"Barahmani","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.246805-10","first-page":"16","volume-title":"The genetic epidemiology of alopecia areata in China","author":"Yang","year":"2004","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0974-7753.246805-11","first-page":"1055","volume-title":"Profile of 513 patients with alopecia areata: Associations of disease subtypes with atopy, autoimmune disease and positive family history","author":"Goh","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0974-7753.246805-12","first-page":"85","volume-title":"Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis","author":"Lew","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.246805-13","doi-asserted-by":"crossref","unstructured":"Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev 2008;16(2):CD004413","DOI":"10.1002\/14651858.CD004413.pub2"},{"key":"key-10.4103\/0974-7753.246805-14","first-page":"55","volume-title":"Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector","author":"Abell","year":"1973","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0974-7753.246805-15","first-page":"338","volume-title":"Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study","author":"Chu","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.246805-16","first-page":"287","volume-title":"Placebo-controlled oral pulse prednisolone therapy in alopecia areata","author":"Kar","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.246805-17","first-page":"1375","volume-title":"Twice weekly 5 mg betamethasone oral pulse therapy in the treatment of alopecia areata","author":"Agarwal","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0974-7753.246805-18","first-page":"597","volume-title":"Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients","author":"Friedli","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.246805-19","first-page":"320","volume-title":"Pulse corticosteroid therapy for alopecia areata: Study of 139 patients","author":"Nakajima","year":"2007","journal-title":"Dermatology"},{"key":"key-10.4103\/0974-7753.246805-20","first-page":"372","volume-title":"A systematic review of pulse steroid therapy for alopecia areata","author":"Shreberk-Hassidim","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.246805-21","first-page":"632","volume-title":"The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis","author":"Joly","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.246805-22","first-page":"507","volume-title":"Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis","author":"Chartaux","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"key-10.4103\/0974-7753.246805-23","first-page":"113","volume-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"key-10.4103\/0974-7753.246805-24","first-page":"S28","volume-title":"The biology of IL-15: Implications for cancer therapy and the treatment of autoimmune disorders","author":"Waldmann","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"key-10.4103\/0974-7753.246805-25","first-page":"545","volume-title":"Emerging treatments in alopecia","author":"Falto-Aizpurua","year":"2014","journal-title":"Expert Opin Emerg Drugs"},{"key":"key-10.4103\/0974-7753.246805-26","first-page":"989","volume-title":"Inhibiting Janus kinases to treat alopecia areata","author":"Divito","year":"2014","journal-title":"Nat Med"},{"key":"key-10.4103\/0974-7753.246805-27","first-page":"2988","volume-title":"Killing two birds with one stone: Oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis","author":"Craiglow","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0974-7753.246805-28","first-page":"1043","volume-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"key-10.4103\/0974-7753.246805-29","first-page":"351","volume-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"key":"key-10.4103\/0974-7753.246805-30","first-page":"22","volume-title":"Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients","author":"Liu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.246805-31","first-page":"29","volume-title":"Tofacitinib for the treatment of alopecia areata and variants in adolescents","author":"Craiglow","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.246805-32","first-page":"102","volume-title":"Transient efficacy of tofacitinib in alopecia areata universalis","author":"Anzengruber","year":"2016","journal-title":"Case Rep Dermatol"},{"key":"key-10.4103\/0974-7753.246805-33","first-page":"727","volume-title":"Off-label use in dermatological practice.The conflict between professional duty and legal requirements","author":"Brunne","year":"2004","journal-title":"Hautarzt"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:35:45Z","timestamp":1786732545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_62_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"alternative-id":["246805"],"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_62_18","relation":{},"ISSN":["0974-7753"],"issn-type":[{"value":"0974-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}